# Long-term Elobixibat for Chronic Constipation

> **NCT04784780** · PHASE4 · UNKNOWN · sponsor: **Yokohama City University** · enrollment: 100 (estimated)

## Conditions studied

- Chronic Constipation

## Interventions

- **DRUG:** Elobixibat 10mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04784780
- **Lead sponsor:** Yokohama City University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-06
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04784780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04784780, "Long-term Elobixibat for Chronic Constipation". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04784780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
